Ekso Bionics Reports Fourth Quarter and Year End 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/25/2026
- Wall St edges up on AI enthusiasm, Mideast negotiation hopes
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices drop about 3% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- S&P 500 ends marginally lower as investors focus on US-Iran war
Ekso Bionics (EKSO) Misses Q4 EPS by 2c
March 28, 2023 4:28 PM EDTEkso Bionics (NASDAQ: EKSO) reported Q4 EPS of ($0.24), $0.02 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $3.6 million versus the consensus estimate of $3.94 million.
For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.
... More